PVCT insider filings
PROVECTUS BIOPHARMACEUTICALS, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-10-23. Screen PVCT transaction legs live →
Insider transaction summary — last 90 days
2026-07-26 to 2026-10-24, from the filings listed below: 7 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Pershing Edward — CEO, Director, 10% owner | 7 | — | — | 14 |
Recent insider filings — PROVECTUS BIOPHARMACEUTICALS, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-23 | 4 | Pershing Edward — CEO, Director, 10% owner | Option exercise (M) @ $0 · Option exercise (M): 7,599 (derivative) @ $0 | EDGAR |
| 2026-10-13 | 4 | Pershing Edward — CEO, Director, 10% owner | Option exercise (M) @ $0 · Option exercise (M): 22,609 (derivative) @ $0 | EDGAR |
| 2026-10-05 | 4 | Pershing Edward — CEO, Director, 10% owner | Option exercise (M) @ $0 · Option exercise (M): 13,216 (derivative) @ $0 | EDGAR |
| 2026-09-18 | 4 | Pershing Edward — CEO, Director, 10% owner | Option exercise (M) @ $0 · Option exercise (M): 13,216 (derivative) @ $0 | EDGAR |
| 2026-09-11 | 4 | Pershing Edward — CEO, Director, 10% owner | Option exercise (M) @ $0 · Option exercise (M): 13,216 (derivative) @ $0 | EDGAR |
| 2026-09-08 | 4 | Pershing Edward — CEO, Director, 10% owner | Option exercise (M) @ $0 · Option exercise (M): 11,328 (derivative) @ $0 | EDGAR |
| 2026-08-26 | 4 | Pershing Edward — CEO, Director, 10% owner | Option exercise (M) @ $0 · Option exercise (M): 11,328 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Pershing Edward — CEO, Director, 10% owner | Grant/award (A): 45,860 (derivative) @ $0 | EDGAR |
| 2026-06-30 | 4 | Bailey Webster — Director | Grant/award (A): 48,917 (derivative) @ $0 | EDGAR |
| 2026-06-30 | 4 | Lacey John III — Director | Grant/award (A): 48,917 (derivative) @ $0 | EDGAR |
| 2026-06-30 | 4 | Rodrigues Dominic — PRESIDENT, Director | Grant/award (A): 45,860 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Pershing Edward — CEO, Director | Option exercise (M) @ $0 · Option exercise (M): 9,436 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2026-05-26 | 4 | Pershing Edward — CEO, Director | Option exercise (M) @ $0 · Option exercise (M): 32,089 (derivative) @ $0 | EDGAR |
| 2026-05-15 | 4 | Pershing Edward — CEO, Director | Option exercise (M) @ $0 · Option exercise (M): 22,651 (derivative) @ $0 | EDGAR |
| 2026-05-07 | 4 | Pershing Edward — CEO, Director | Option exercise (M) @ $0 · Option exercise (M): 18,876 (derivative) @ $0 | EDGAR |
| 2026-04-29 | 4 | Pershing Edward — CEO, Director | Option exercise (M) @ $0 · Option exercise (M): 30,202 (derivative) @ $0 | EDGAR |
| 2026-04-06 | 4 | Pershing Edward — CEO, Director | Option exercise (M) @ $0 · Option exercise (M): 33,977 (derivative) @ $0 | EDGAR |
| 2026-03-26 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2026-03-20 | 4 | Pershing Edward — CEO, Director | Option exercise (M) @ $0 · Option exercise (M): 49,067 (derivative) @ $0 | EDGAR |
| 2026-03-16 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2026-03-06 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2026-02-27 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2026-02-23 | 4 | Pershing Edward — CEO, Director | Option exercise (M) @ $0 · Option exercise (M): 47,180 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2026-02-17 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2026-02-11 | 4 | Pershing Edward — CEO, Director | Purchase (P): 34,940 (derivative) @ $2.86 | EDGAR |
| 2026-02-09 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2026-02-02 | 4 | Pershing Edward — CEO, Director | Option exercise (M) @ $0 · Option exercise (M): 37,744 (derivative) @ $0 | EDGAR |
| 2026-01-29 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2026-01-16 | 4 | Pershing Edward — CEO, Director | Option exercise (M) @ $0 · Option exercise (M): 37,744 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2025-12-08 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2025-11-28 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2025-11-21 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2025-11-14 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2025-11-07 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2025-10-31 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2025-10-24 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2025-10-17 | 4 | Pershing Edward — CEO, Director | Option exercise (M) @ $0 · Option exercise (M): 18,880 (derivative) @ $0 | EDGAR |
| 2025-10-14 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2025-10-09 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2025-09-30 | 4 | Pershing Edward — CEO, Director | Option exercise (M) @ $0 · Option exercise (M): 66,052 (derivative) @ $0 | EDGAR |
| 2025-09-19 | 4 | Pershing Edward — CEO, Director | Option exercise (M) @ $0 · Option exercise (M): 37,760 (derivative) @ $0 | EDGAR |
| 2025-09-19 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2025-09-12 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2025-09-05 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2025-08-29 | 4 | Pershing Edward — CEO, Director | Option exercise (M) @ $0 · Option exercise (M): 28,320 (derivative) @ $0 | EDGAR |
| 2025-08-27 | 4 | Pershing Edward — CEO, Director | Grant/award (A) @ $0 | EDGAR |
| 2025-08-22 | 4 | Pershing Edward — CEO, Director | Option exercise (M) @ $0 · Option exercise (M): 37,760 (derivative) @ $0 | EDGAR |
Recent 8-K events — PROVECTUS BIOPHARMACEUTICALS, INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-01 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-22 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-18 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-21 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-02 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-20 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-06-18 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-04-16 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-01-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-12-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PVCT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs